Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ocular Therapeutix Inc. (OCUL)

3.59   -0.16 (-4.27%) 01-23 16:00
Open: 3.76 Pre. Close: 3.75
High: 3.8 Low: 3.57
Volume: 344,187 Market Cap: 148M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.825 - 3.862 3.862 - 3.884
Low: 3.495 - 3.541 3.541 - 3.569
Close: 3.537 - 3.612 3.612 - 3.658

Technical analysis

as of: 2019-01-23 4:30:01 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.49     One year: 6.32
Support: Support1: 3.55    Support2: 2.95
Resistance: Resistance1: 4.70    Resistance2: 5.41
Pivot: 4.00
Moving Average: MA(5): 3.84     MA(20): 4.01
MA(100): 5.52     MA(250): 6.00
MACD: MACD(12,26): -0.31     Signal(9): -0.32
Stochastic oscillator: %K(14,3): 21.65     %D(3): 33.10
RSI: RSI(14): 28.99
52-week: High: 8.28  Low: 3.55  Change(%): -42.0
Average Vol(K): 3-Month: 56291  10-Days: 36600

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OCUL has closed below the lower band by 10.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 47.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to OCUL's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Ocular Therapeutix(TM) Submits Supplemental New Drug Application (sNDA) for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 41.10
Shares Float (M) 39.84
% Held by Insiders
% Held by Institutions 78.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.590
EPS Est. Current Year -2.290
EPS Est. Next Year -2.110
EPS Est. Next Quarter -0.530
Forward EPS -1.381
Book Value (p.s.) 3.570
PEG Ratio
Profit Margin
Operating Margin -2637.86
Return on Assets (ttm) -83.1
Return on Equity (ttm) -137.4
Qtrly Rev. Growth -4.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -45.96
Levered Free Cash Flow (M) -25.55

Stock Valuations

P/E -2.26
P/E Growth Ratio -0.04
P/BV 1.01
P/S 2469920000.00
P/CF -3.21

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.